The FDA's pilot program, project renewal, uses capecitabine for its first label makeover.  What's new & what are the possible implications of the DPYD warning now in the prescribing information?

2022 New Drug Review

OncoPharm is a podcast dedicated to all things oncology pharmacy.  Most episodes cover updates and recent publications concerning the use of medications in caring for patients we cancer.  Periodically, episodes drop devoted to Landmark Clinical Trials in oncology and Fundamentals of Oncology Pharmacy.